Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay

Journal of Clinical Investigation

Volumn 94, Issue 6, 1994, Pages 2475-2480

  Klein, Karen Oerter ^c,d,e   Baron, Jeffrey ^a,e   Colli, Michael J ^a   McDonnell, Donald P ^b   Cutler Jr , Gordon B ^a,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e United States Public Health Service

Author keywords

estradiol; estrogen; prepubertal; Saccharomyces cerevisiae; yeast

Indexed keywords

ADOLESCENT; ARTICLE; BIOASSAY; CHILD; DIAGNOSTIC ACCURACY; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; MALE; NORMAL HUMAN; PREPUBERTY; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

EID: 0028007173     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117616     Document Type: Article

References (46)

1. Garibaldi, L. R., T. Aceto, Jr., and C. Weber. 1993. The pattern of gonadotropin and estradiol secretion in exaggerated thelarche. Acta Endocrinol. 128:345-350.
2. Marshall, W. A., and J. M. Tanner. 1969. Variations in the pattern of pubertal changes in girls. Arch. Dis. Child. 44:291-303.
3. Caruso-Nicoletti, M., F. Cassorla, M. Skerda, J. L. Ross, D. L. Loriaux, and G. B. Cutler, Jr. 1985. Short term, low dose estradiol accelerates ulnar growth in boys. J. Clin. Endocrinol. & Metab. 61:896-898.
4. Vanderschueren-Lodeweyckx, M., G. Massa, M. Maes, M. Craen, G. Van-Vliet, C. Heinrichs, and P. Malvaux. 1990. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner syndrome. J. Clin. Endocrinol. & Metab. 70:122-126.
5. Ross, J. L., F. G. Cassorla, M. C. Skerda, I. M. Valk, D. L. Loriaux, and G. B. Cutler, Jr. 1983. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N. Engl. J. Med. 309:1104-1106.
6. Ross, J. L., F. G. Cassorla, G. Carpenter, L. M. Long, M. S. Royster, D. L. Loriaux, and G. B. Cutler, Jr. 1988. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner syndrome. J. Clin. Endocrinol. & Metab. 67:515-518.
7. Greulich, W. W., and S. I. Pyle. 1959. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford University Press, Stanford, CA. 255 pp.
8. Laue, L., J. Jones, K. M. Barnes, and G. B. Cutler, Jr. 1993. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J. Clin. Endocrinol. & Metab. 76:151-155.
9. Forest, M. G., E. Peretti, and J. Bertrand. 1976. Hypothalamic-pituitary-gonadal relationships in man from birth to puberty, Clin. Endocrinol. 5:551-569.
10. Reyes, F. I., R. S. Boroditsky, J. S. D. Winter, and C. Faiman. 1974. Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations. J. Clin. Endocrinol. & Metab. 8:612-617.
11. Shutt, D. A., L. D. Smith, and R. P. Shearman. 1974. Oestrone, oestradiol-17beta and oestriol levels in human foetal plasma during gestation and at term. J. Endocrinol. 60:333-341.
12. Kenny, F. M., Angsusingha, D. Stinson, and H. Hotchkiss. 1973. Unconjugated estrogens in the perinatal period. Pediatr. Res. 7:826-831.
13. Bidlingmaier, F., M. Wagner-Barnack, O. Butenandt, and D. Knorr. 1973. Plasma estrogens in childhood and puberty under physiologic and pathologic conditions. Pediatr. Res. 7:901-907.
14. Baker, H. W., H. G. Burger, D. M. deKretser, B. Hudson, S. O'Connor, C. Wang, A. Mirovics, J. Court, M. Dunlop, and G. C. Rennie. 1976. Changes in the pituitary-testicular system with age. Clin. Endocrinol. 5:349-372.
15. Belgorosky, A., and M. A. Rivarola. 1988. Progressive increase in non sex hormone-binding globulin-bound testosterone and estradiol from infancy to late prepuberty in girls. J. Clin. Endocrinol. & Metab. 67:234-237.
16. Ducharme, J. R., M. G. Forest, E. Peretti, M. Sempe, R. Collu, and J. Bertrand. 1976. Plasma adrenal and gonadal sex steroids in human pubertal development. J. Clin. Endocrinol. & Metab. 42:468-476.
17. Picard, D., B. Khursheed, M. J. Garabedian, M. G. Fortin, S. Lindquist, and K. R. Yamamoto. 1990. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature (Lond.). 348:166-168.
18. Fuqua, S. A. W., S. D. Fitzgerald, G. C. Chamness, A. K. Tandon, D. P. McDonnell, Z. Nawaz, B. W. O'Malley, and W. L. McGuire. 1991. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 51:105-109.
19. McDonnell, D. P., Z. Nawaz, C. Densmore, N. L. Weigel, T. A. Pham, J. H. Clark, and B. W. O'Malley. 1991. High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. J. Steroid Biochem. Mol. Biol. 39:291-297.
20. Pham, T. A., Y. -P. Hwung, D. Santiso-Mere, D. P. McDonnell, and B. W. O'Malley. 1992. Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol. Endocrinol. 6:1043-1050.
21. Moehle, C. M., M. W. Ayanardi, M. R. Kolodny, F. J. Park, and E. W. Jones. 1987. Protease B of Sacchromyces cerevisiae: isolation and regulation of the PRB1 structural gene. Genetics. 115:255-263.
22. Menzel, R. 1989. A microtiter plate-based system for the semiautomated growth and assay of bacterial cells for β-galactosidase activity. Anal Biochem. 181:40-50.
23. Yocum, R. R., S. Hanley, R. West, Jr., and M. Pitashne. 1984. Use of lacZ fusions to delimit regulatory elements of the inducible divergent GAL1-GAL10 promoter in Sacchromyces cerevisiae. Mol. Cell. Biol. 4:1985- 1998.
24. Miller, J. H. 1972. Experiments in Molecular Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 352-355.
25. Allen, E., and E. A. Doisy. 1923. Ovarian hormone. JAMA J. Am.( Med. Assoc.). 81:819-821.
26. Martin, L., and P. J. Claringbold. 1960. The mitogenic action of oestrogens in the vaginal epithelium of the ovariectomized mouse. J. Endocrinol. 20:173-186.
27. Martin, L. 1960. The use of 2-3-5-triphenyltetrazolium chloride in the biological assay of oestrogens. J. Endocrinol. 20:187-197.
28. Lauson, H. D., C. G. Heller, J. B. Golden, and J. B. Sevringhaus. 1939. Immature rat uterus in the assay of estrogenic substances and a comparison of estradiol, estrone and estriol. Endocrinology. 24:35-44.
29. Evans, J. S., L. Hines, R. Varney, and F. C. Koch. 1940. The comparative assay of gonadotropic substances on rats, mice and chicks. Endocrinology. 26:1005.
30. Dorfman, R. I., and A. S. Dorfman. 1954. Estrogen assays using the rat uterus. Endocrinology. 55:65.
31. Ittrich, S., E. Forchielli, W. H. Perjoff, and I. Dorfman. 1963. Methods of biochemical analysis. In Interscience. Vol. 2. D. Glic, editor. New York. 69.
32. Bates, R. W., and H. Cohen. 1950. Experimental basis for selecting the optimal conditions for quantitative fluorometry of natural estrogens. Endocrinology. 47:166-192.
33. Abraham, G. E. 1975. Radioimmunoassay of steroids in biological fluids. J. Steroid Biochem. 6:261.
34. Loriaux, D. L., H. J. Ruder, and M. B. Lipsett. 1971. The measurement of estrone sulfate in plasma. Steroids. 18:463-472.
35. Ruder, H. J., L. Loriaux, and M. B. Lipsett. 1972. Estrone sulfate: production rate and metabolism in man. J. Clin. Invest. 51:1020-1033.
36. Nagai, N., and C. Longcope. 1971. Estradiol-17β and estrone: studies on their binding to rabbit uterine cytosol and their concentration in plasma. Steroids 17:631-647.
37. Spratt, D. I., C. Longcope, P. M. Cox, and S. T. Bigos. 1993. Differential changes in serum concentration of androgens and estrogens (in relation with cortisol) in postmenopausal women with acute illness. J. Clin. Endocrinol. & Metab. 76:1542-1547.
38. Longcope, C., C. Franz, C. Morello, R. Baker, and C. C. Johnston, Jr. 1986. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas. 8:189-196.
39. Longcope, C., and J. H. Pratt. 1978. Relationship between urine and plasma estrogen ratios. Cancer Res. 38:4025-4028.
40. Longcope, C., D. Watson, and K. I. Williams. 1974. The effects of synthetic estrogens on the metabolic clearance and production rates of estrone and estradiol. Steroids. 24:15-30.
41. England, B. G., G. D. Niswender, and A. R. Midgley, Jr. 1974. Radioimmunoassay of estradiol-17 beta without chromatography. J. Clin. Endocrinol. &. Metab. 38:42-50.
42. Korenman, S. G., R. H. Stevens, L. A. Carpenter, M. Robb, G. D. Niswender, and B. M. Sherman. 1974. Estradiol radioimmunoassay without chromatography: procedure, validation and normal values. J. Clin. Endocrinol. & Metab. 38:718-720.
43. Hansen, J. W., H. J. Hoffman, and G. T. Ross. 1975. Monthly gonadotropin cycles in premenarcheal girls. (Wash. DC)Science. 190:161-163.
44. Pescovitz, O. H. 1993. The clinical spectrum of female isosexual precocious puberty. In Sexual Precocity. G. D. Grave and G. B. Cutler, Jr., editors. Raven Press, New York 97-108.
45. Boepple, P. A., M. J. Mansfield, H. Landy, and W. F. Crowley, Jr. 1993. GnRH agonist therapy of central precocious puberty: should the goal be complete pituitary-gonadal suppression? In Sexual Precocity. G. D. Grave and G. B. Cutler, Jr., editors. Raven Press, New York. 11-26.
46. Demers, L. M., A. Lipton, H. A. Harvey, K. B. Kambic, H. Grossberg, C. Brady, and R. J. Santen. 1993. The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer. J. Steroid Biochem. Mol. Biol. 44:687-691.